Trials / Completed
CompletedNCT00043030
Evaluating Patient Participation in Phase I Clinical Trials
Survey Of Patient's Motivations, Perceptions, And Expectations In Phase I Clinical Trials
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- National Institutes of Health Clinical Center (CC) · NIH
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
RATIONALE: Understanding why patients participate in a phase I clinical trial may help doctors plan better treatment for cancer. PURPOSE: This clinical trial is studying to determine the reasons for participation, perceptions, and expectations of patients receiving treatment for cancer in phase I clinical trials.
Detailed description
OBJECTIVES: * Describe the motivations, perceptions, and expectations of patients enrolled in a phase I clinical trial. * Assess the influence of age, education, and gender upon the perception of these patients. * Compare the difference in perceptions, motivations, and expectations of patients who have previously participated in a phase I clinical trial vs those who have not. * Determine whether patients' perceptions, motivations, and expectations change while enrolled in a phase I clinical trial. * Validate an interviewer-administered tool measuring the perceptions, motivations, and expectations of these patients. * Assess patients' perception of the information they were given while enrolled in a phase I clinical trial. OUTLINE: Patients are interviewed over the phone to evaluate their perceptions, motivations, and expectations of phase I clinical trials. Patients complete a questionnaire comprising 24 questions over 30-45 minutes. Interviews are conducted within 1 week after enrolling in a phase I clinical trial (prior to the first dose of study agent) and then again 2 months later (or at the time the patient stops treatment). The first 10 patients enrolled complete an additional 6 questions over 15 minutes during the first interview to validate the questionnaire, but do not complete a second interview. PROJECTED ACCRUAL: A total of 120 patients will be accrued for this study within 1 year.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | psychosocial assessment and care |
Timeline
- Start date
- 2002-06-01
- Primary completion
- 2006-12-01
- Completion
- 2009-05-01
- First posted
- 2003-01-27
- Last updated
- 2012-03-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00043030. Inclusion in this directory is not an endorsement.